Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Market Insights and Forecast (2020-2030)

Analysis by Type (Tirzepatide, Semaglutide, Dulaglutide, Others), End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution Channel, By Route of Administration, By Region, By Country

Published	Pages	Publisher	Report code
Feb 2024	250	Azoth Analytics	ASDR-654804

Published: Feb 2024 - Pages : 250 - Publisher : Azoth Analytics - Report code : ASDR-654804

Eli Lilly and Company
Pfizer
Sanofi
AstraZeneca PLC
Boehringer Ingelheim
and Novo Nordisk.